Insider · CIK 0001135041

CHANG NANCY T

Reports to the SEC for 9 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001135041

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	GRTXGalera Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−47.4K sh	—	—	0
2026-08-03	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−480 sh	—	—	0
2026-07-15	WTIW&T OFFSHORE INCS Sale	Director	SSale	−60K sh	$3.31	−$199K	156,100
2026-06-03	WTIW&T OFFSHORE INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−103K sh	—	—	0
2026-06-03	WTIW&T OFFSHORE INC · Restricted Stock UnitsA Award	Director	AAward	+36K sh	—	—	35,972
2026-06-03	WTIW&T OFFSHORE INCM Exercise/Conversion	Director	MExercise/Conversion	+103K sh	—	—	216,100
2026-05-22	IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2026-05-22	IMMXImmix Biopharma, Inc.A Award	Director	AAward	+6,250 sh	—	—	428,190
2026-05-15	GRTXGalera Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−661.309 sh	—	—	0
2026-05-15	GRTXGalera Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+661K sh	—	—	9,486,852
2026-04-07	GRTXGalera Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1,180.611 sh	—	—	661.309
2026-04-07	GRTXGalera Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+1.18M sh	—	—	8,825,543
2025-11-21	IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39.6K sh	—	—	39,643
2025-06-03	WTIW&T OFFSHORE INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−73.9K sh	—	—	0
2025-06-03	WTIW&T OFFSHORE INCM Exercise/Conversion	Director	MExercise/Conversion	+73.9K sh	—	—	112,652
2025-06-03	WTIW&T OFFSHORE INC · Restricted Stock UnitsA Award	Director	AAward	+103K sh	—	—	103,448
2025-02-24	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+96K sh	—	—	96,000
2024-12-30	GRTXGalera Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+7.64M sh	$0.07	+$500K	7,644,932
2024-12-30	GRTXGalera Therapeutics, Inc. · Series B Preferred StockA Award	Director, 10% Owner	AAward	+1,841.92 sh	—	—	1,841.92
2024-06-17	WTIW&T OFFSHORE INCM Exercise/Conversion	Director	MExercise/Conversion	+38.8K sh	—	—	38,760
2024-06-17	WTIW&T OFFSHORE INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−38.8K sh	—	—	0
2024-06-14	WTIW&T OFFSHORE INC · Restricted Stock UnitsA Award	Director	AAward	+73.9K sh	—	—	73,892
2023-07-03	WTIW&T OFFSHORE INC · Restricted Stock UnitsA Award	Director	AAward	+38.8K sh	—	—	38,760
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$2.03	−$60.9K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−70K sh	$11.18	−$783K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$0.28	−$8,400	0
2017-06-08	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2016-09-29	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+33.3K sh	$5.22	+$174K	70,000
2016-09-29	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,648 sh	—	—	0
2016-09-29	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−33.3K sh	—	—	0
2016-09-29	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+7,648 sh	$5.10	+$39K	36,667
2016-08-30	SCICLONE PHARMACEUTICALS INCS Sale	Director	SSale	−7,540 sh	$10.33	−$77.9K	0
2016-08-29	SCICLONE PHARMACEUTICALS INCS Sale	Director	SSale	−10K sh	$10.31	−$103K	7,540
2016-08-26	SCICLONE PHARMACEUTICALS INCS Sale	Director	SSale	−7,500 sh	$10.25	−$76.9K	17,540
2016-06-09	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-06-11	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-02-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)A Award	Director	AAward	−16.7K sh	—	—	33,333
2015-02-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.4K sh	—	—	7,648
2015-02-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$5.22	+$87K	54,059
2015-02-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.4K sh	$5.10	+$63K	37,392
2014-08-15	SCICLONE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+25K sh	$6.00	+$150K	25,040
2013-09-17	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2010-05-07	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)A Award	Director	AAward	+10.7K sh	—	—	10,710
2010-05-07	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Director	AAward	+2,980 sh	—	—	31,010
2009-05-08	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)A Award	Director	AAward	+10.4K sh	—	—	10,440
2009-05-08	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Director	AAward	+2,530 sh	—	—	28,030
2008-11-17	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Director	AAward	+10.5K sh	$23.86	+$251K	25,500
2006-07-10	TANOX INCS Sale	Director, 10% Owner	SSale	−5,000 sh	$14.12	−$70.6K	3,706,879
2006-07-05	TANOX INCS Sale	Director, 10% Owner	SSale	−1,410 sh	$14.02	−$19.8K	3,711,879
2006-07-03	TANOX INCS Sale	Director, 10% Owner	SSale	−3,590 sh	$14.00	−$50.3K	3,713,289

Recent filings

Accepted (ET)
Aug 54
CHANG NANCY T0001193125-26-335224
SEC(opens sec.gov)
Jul 164
CHANG NANCY T0001104659-26-084282
SEC(opens sec.gov)
Jun 54
CHANG NANCY T0001104659-26-071066
SEC(opens sec.gov)
May 294
CHANG NANCY T0001493152-26-026426
SEC(opens sec.gov)
Apr 94
CHANG NANCY T0000905148-26-001622
SEC(opens sec.gov)
Dec 114
CHANG NANCY T0001493152-25-027329
SEC(opens sec.gov)
Jun 54
CHANG NANCY T0001104659-25-056883
SEC(opens sec.gov)
Feb 264
CHANG NANCY T0000905148-25-000786
SEC(opens sec.gov)
Jan 24
CHANG NANCY T0000905148-25-000010
SEC(opens sec.gov)
Jun 184
CHANG NANCY T0001104659-24-072857
SEC(opens sec.gov)

Companies

Address

C/O GALERA THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 225

MALVERN, PA, 19355